Allegaert, K., Rayyan, M., Cossey, V. and Van Geet, C. (2015) “Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease”, Journal of Pediatric and Neonatal Individualized Medicine (JPNIM). Quartu Sant’Elena (CA, Italy), 4(1), p. e040104. doi: 10.7363/040104.